BIOCYTOGEN-B(02315),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02315 BIOCYTOGEN-B

Trading 04-14 14:01:55

58.450

+1.450

+2.54%

High61.500	Low57.000	Vol1.45M
Open57.050	D1 Closing57.000	Amplitude7.89%
Mkt Cap26.13B	Tradable Cap6.49B	Total Shares447.00M
T/O85.83M	T/O Rate1.30%	Tradable Shares111.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02315","market":"HK","secType":"STK","nameCN":"BIOCYTOGEN-B","latestPrice":58.45,"timestamp":1776146509918,"preClose":57,"halted":0,"volume":1446000,"delay":0,"changeRate":0.02543859649122812,"floatShares":111000000,"shares":447000000,"eps":0.43,"marketStatus":"Trading","change":1.45,"latestTime":"04-14 14:01:55","open":57.05,"high":61.5,"low":57,"amount":85833973,"amplitude":0.078947,"askPrice":58.7,"askSize":3000,"bidPrice":58.45,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":0.429,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1776154200000},"marketStatusCode":2,"adr":0,"listingDate":1661961600000,"exchange":"SEHK","adjPreClose":57,"openAndCloseTimeList":[[1776130200000,1776139200000],[1776142800000,1776153600000]],"volumeRatio":1.345638,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688796","market":"SH","secType":"STK","nameCN":"Biocytogen Pharmaceuticals (Beijing) Co.,Ltd.","latestPrice":100.81,"timestamp":1776146512000,"preClose":99.6,"halted":0,"volume":2573400,"delay":0,"premium":"-49.54"}},"requestUrl":"/m/hq/s/02315/tweets","defaultTab":"tweets","newsList":[{"id":"2624663980","title":"Asian Growth Companies With High Insider Ownership In April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2624663980","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624663980?lang=en_us&edition=fundamental","pubTime":"2026-04-03 06:08","pubTimestamp":1775167686,"startTime":"0","endTime":"0","summary":"As geopolitical tensions and energy market volatility dominate the global landscape, Asian markets have been navigating these challenges with a focus on resilience and growth. Amidst this backdrop, companies in Asia with high insider ownership are often seen as attractive prospects due to their potential for aligned interests between management and shareholders, offering a unique perspective in times of uncertainty.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9621091-choice2-main-header/1585186855318","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9621091-choice2-main-header/1585186855318"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/automobiles/hkg-2889/pateo-connect-technology-shanghai-shares/news/asian-growth-companies-with-high-insider-ownership-in-april-4","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/automobiles/hkg-2889/pateo-connect-technology-shanghai-shares/news/asian-growth-companies-with-high-insider-ownership-in-april-4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199722588","title":"Biocytogen-B Shares Surge Over 5% in Morning Session Following Formal Strategic Partnership Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=1199722588","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199722588?lang=en_us&edition=fundamental","pubTime":"2026-04-02 11:40","pubTimestamp":1775101239,"startTime":"0","endTime":"0","summary":"Biocytogen-B (02315) saw its shares rise more than 6% during the trading session. At the time of writing, the stock was up 5.29%, trading at HK$62.70, with a turnover of HK$56.9547 million. Sihuan...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","688796","02315","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141444588","title":"Biocytogen-B Shares Extend Rally with Over 6% Gain on AI-Driven Obesity Drug Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=1141444588","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141444588?lang=en_us&edition=fundamental","pubTime":"2026-04-02 11:36","pubTimestamp":1775100980,"startTime":"0","endTime":"0","summary":"Biocytogen-B (02315) rose more than 6% again, reaching HK$63.3 at the time of writing, with a trading volume of HK$56.0117 million. The increase follows the announcement of a formal strategic...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","AIPO","BK1161","02315","BK0216","BK1574","VXUS","00460","BK1191","159992","BK4585","06978","AGIX","CHAT","BK1593","BK1600","BK1515","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114582605","title":"Stock Track | BIOCYTOGEN-B Soars 5.12% Intraday on Strategic Collaboration for Weight Loss Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1114582605","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114582605?lang=en_us&edition=fundamental","pubTime":"2026-04-02 10:51","pubTimestamp":1775098276,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B's stock price soared 5.12% during the intraday session on Thursday, following the announcement of a significant strategic partnership.The surge is attributed to the company entering into...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158222835","title":"Hong Kong Stock Announcement Highlights | Biocytogen-B and Sihuan Pharmaceutical Form Strategic Partnership to Accelerate Innovative Drug Development in Weight Loss and Other Areas","url":"https://stock-news.laohu8.com/highlight/detail?id=1158222835","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158222835?lang=en_us&edition=fundamental","pubTime":"2026-04-02 09:21","pubTimestamp":1775092887,"startTime":"0","endTime":"0","summary":"Major Developments: Biocytogen-B (02315) and Sihuan Pharmaceutical (00460) have entered into a strategic collaboration to accelerate the research and development of innovative drugs in multiple...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0307460666.USD","00460","LU0605514214.HKD","BK4588","SG9999015986.USD","LU0214875030.USD","LU1251922891.USD","BK1582","GELYY","LU1303224171.USD","LU0819121731.USD","SG9999015945.SGD","LU0211977185.USD","BK1119","BK1240","LU0293314216.USD","EVS.SI","LU0823414478.USD","LU0588545730.USD","SG9999002463.SGD","LU1861214812.USD","BK1521","LU0588546209.SGD","BK1539","LU0823039010.USD","LU0417516738.SGD","LU0819123356.HKD","BK1600","LU0588545490.SGD","BK1594","LU2249611893.SGD","IE00BZ08YT58.USD","LU0572944931.SGD","LU0143863198.USD","LU0175139822.USD","LU0320764599.SGD","LU0865486749.SGD","LU2153592121.USD","LU0708995583.HKD","LU0593848301.USD","LU2294711713.HKD","LU0594300419.USD","LU0043850808.USD","LU0359201885.HKD","LU0516423091.SGD","LU0823426480.USD","LU0823038988.USD","LU2039709279.SGD","BK1610","LU0417516902.SGD","LU2097828557.USD","IE00BZ08YR35.GBP","LU1242518931.SGD","LU1720050803.USD","LU0348735423.USD","LU1868837722.USD","BK1589","002594","LU0516422952.EUR","LU0254981946.USD","SG9999001226.SGD","LU1861219969.SGD","BK1191","LU0359202008.SGD","LU0165289439.USD","LU1880383440.USD","LU0259732245.USD","LU0289960550.SGD","LU0871576103.HKD","SG9999015978.USD","LU0039217434.USD","LU1880383366.USD","SG9999006597.SGD","LU0164872284.USD","LU0164865239.USD","LU0084288322.USD","LU0463099449.HKD","LU1224444064.USD","BYDDY","BK1124","LU2097828631.EUR","SG9999002828.SGD","LU1868838027.USD","LU1770034418.SGD","LU0289961442.SGD","LU2097828714.EUR","LU0509642566.USD","BK1509","BK1515","LU0588545904.SGD","BK1540","LU0244354667.USD","LU0828238088.HKD","81211","LU0531971595.HKD","LU1188198961.HKD","HYDD.SI","LU0348805143.USD","LU0543330566.HKD","LU1813983027.USD","LU0856984785.SGD","LU0469268626.HKD","LU1794554557.SGD","LU2399975544.HKD","BK1522","LU1023057109.AUD","LU2506951792.HKD","LU0359201612.USD","LU0650527681.SGD","BK1574","LU0823414551.USD","LU1868837565.USD","LU0052750758.USD","LU2778985437.USD","LU0314109678.HKD","LU1328277881.USD","BK1161","LU0054450605.USD","IE00B0JY6N72.USD","LU1282651048.USD","SG9999015952.SGD","LU0348827113.USD","LU0505663152.USD","BK1593","LU1282651121.HKD","IE00BD6J9T35.USD","LU0823426308.USD","LU2476274308.USD","LU0315179316.USD","LU1961090484.USD","LU0143863784.USD","BK4585","LU0449515922.USD","LU2097828474.EUR","02315","LU0327786744.USD","LU0516422440.USD","LU0516422366.SGD","LU2097828805.USD","LU0979878070.USD","LU0348825331.USD","LU2476274720.SGD","LU0516423174.USD","SG9999006514.SGD","LU0326950275.SGD","LU0289739343.SGD","LU0449509016.USD","LU2348774022.SGD","LU2360107325.USD","LU0540923850.HKD","LU0229945570.USD","LU1719994722.HKD","SG9999014674.SGD","LU0269904917.USD","LU0634319403.HKD","LU0315178854.USD","LU0594300179.USD","LU2357125470.USD","LU0531970944.HKD","LU1242518857.USD","IE00BZ08YS42.EUR","688796","LU0511384066.AUD","LU1808992512.USD","LU2449936058.SGD","LU0561508036.HKD","80175","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122797956","title":"IEA Warns of Doubling Oil Supply Gap in April; US Launches Manned Moon Mission Rocket","url":"https://stock-news.laohu8.com/highlight/detail?id=1122797956","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122797956?lang=en_us&edition=fundamental","pubTime":"2026-04-02 07:43","pubTimestamp":1775087031,"startTime":"0","endTime":"0","summary":"The head of the International Energy Agency (IEA) stated that the oil supply gap in April will double compared to March. Fatih Birol, the IEA chief, mentioned in a podcast released on Wednesday that...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XOP","02256","BK1576","LU1807302812.USD","BK1610","BK1116","BK4588","03750","02315","BK1194","01857","300750","LU1152091168.USD","BK1593","LU0880133367.SGD","03759","300759","688796","LU1960683339.HKD","BK4570","LU1008478684.HKD","BK1161","LU1152091754.HKD","BK1191","LU1993786604.SGD","XLE","BK1141","06681","BK1600","LU0067412154.USD","BK4585","00460","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143375483","title":"SIHUAN PHARM and BIOCYTOGEN-B Forge Strategic Alliance to Accelerate Innovative Drug Development in Weight Loss and Other Areas Using AI-Powered Human Antibody Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1143375483","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143375483?lang=en_us&edition=fundamental","pubTime":"2026-04-01 17:12","pubTimestamp":1775034756,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) has announced that the Group has officially entered into a strategic collaboration agreement with Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Stock Code: 688796.SH;...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1191","BK0216","BK1161","688796","BK1600","BK1593","CHAT","BK1515","02315","06978","AGIX","BK1574","159992","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115704559","title":"BIOCYTOGEN-B (02315) Enters Commercial Realization Phase with 416% Net Profit Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1115704559","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115704559?lang=en_us&edition=fundamental","pubTime":"2026-03-30 09:13","pubTimestamp":1774833190,"startTime":"0","endTime":"0","summary":"The innovative drug sector is experiencing a confluence of positive catalysts in 2026, signaling a clear industry recovery. On the policy front, the government work report for the first time...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315","BK0216","688796","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115925397","title":"Hang Seng Rises on Strategic Trade Countermeasures; Biotech Stocks Lead Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1115925397","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115925397?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:02","pubTimestamp":1774612965,"startTime":"0","endTime":"0","summary":"Market conditions are intensifying despite former President Trump's attempts to de-escalate tensions. On Thursday, he claimed that, at Iran's request, he would delay the \"destruction\" of Iranian...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"69cd48097efa50f044ce5ac6380125f5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","03696","02315","BK1574","BK1141","LU0359202008.SGD","BK1144","LU1023057109.AUD","159992","SG9999006597.SGD","LU0359201612.USD","01276","BK1191","09696","BK1509","03931","06978","LU0359201885.HKD","BK1594","BK4588","01772","LU2543165471.USD","BK1161","VXUS","BK1129","SG9999014674.SGD","SG9999003461.SGD","BK1190","BK1592"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622981768","title":"Biocytogen Pharmaceuticals' 2025 Profit Surges as Revenue Rises 41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622981768","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622981768?lang=en_us&edition=fundamental","pubTime":"2026-03-27 13:42","pubTimestamp":1774590154,"startTime":"0","endTime":"0","summary":"Biocytogen Pharmaceuticals   booked 173.2 million yuan in attributable profit for 2025, rising from 33.5 million yuan in 2024, according to a Hong Kong bourse filing Thursday.Shares of the pharmaceutical firm gained nearly 9% in afternoon trade Friday.Earnings per share were 0.43 yuan, compared with 0.08 yuan in the prior year.Revenue rose 41% year on year to 1.38 billion yuan, figures showed.Meanwhile, in a separate announcement, the firm said its partner NEOK Bio received U.S. Food and Drug Administration approval to begin human trials of NEOK002.The therapy was developed using Biocytogen's RenLite platform and will be studied as a treatment for advanced solid tumors.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174899542","title":"BIOCYTOGEN-B Shares Surge Over 12% on Strong Annual Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1174899542","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174899542?lang=en_us&edition=fundamental","pubTime":"2026-03-27 10:46","pubTimestamp":1774579606,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) rose more than 12% in Hong Kong trading. At the time of writing, the stock was up 11.99% to HK$60.25, with a turnover of HK$78.0872 million. The surge follows the company's...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","VXUS","BK1161","BK0216","02315","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108242718","title":"Stock Track | BIOCYTOGEN-B Soars 5.39% Intraday on Partner's FDA IND Clearance for Bispecific ADC","url":"https://stock-news.laohu8.com/highlight/detail?id=1108242718","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108242718?lang=en_us&edition=fundamental","pubTime":"2026-03-27 09:58","pubTimestamp":1774576729,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B's stock price soared 5.39% during intraday trading on Friday, reflecting significant investor interest.The surge follows news that the company's partner, NEOK Bio, Inc., has received...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114322224","title":"BIOCYTOGEN-B Partner NEOK Bio Secures FDA IND Clearance for Bispecific ADC NEOK002, Reaching Critical Collaboration Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=1114322224","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114322224?lang=en_us&edition=fundamental","pubTime":"2026-03-26 22:39","pubTimestamp":1774535946,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) announced that its partner, NEOK Bio, Inc., has received Investigational New Drug (IND) approval from the US Food and Drug Administration (FDA) for its investigational drug...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","02315","LABU","ADC","IND","BK4080","BK4588","BK4585","BK1161","688796","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126376045","title":"BIOCYTOGEN-B Shares Surge Over 12% Following Strategic Collaboration and Projected Four-Fold Profit Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=1126376045","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126376045?lang=en_us&edition=fundamental","pubTime":"2026-03-24 15:04","pubTimestamp":1774335855,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) rose more than 12% in Hong Kong trading. At the time of writing, the stock was up 12.14% to HK$54.5, with a turnover of HK$160 million. The surge follows an announcement on March...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","688796","BK4588","VXUS","BK4585","02315","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145518081","title":"BIOCYTOGEN-B (02315) Schedules 26 Mar 2026 Board Meeting to Review FY2025 Results and Potential Final Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1145518081","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145518081?lang=en_us&edition=fundamental","pubTime":"2026-03-16 16:41","pubTimestamp":1773650469,"startTime":"0","endTime":"0","summary":"Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (abbrev. BIOCYTOGEN-B, stock code 02315) has set 26 March 2026 for a board meeting, according to an announcement released on 16 March 2026. The agenda...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165728195","title":"Biocytogen-B Shares Surge Over 7% Intraday on Strong Full-Year Profit Guidance and Key Collaboration Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=1165728195","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165728195?lang=en_us&edition=fundamental","pubTime":"2026-03-16 15:50","pubTimestamp":1773647438,"startTime":"0","endTime":"0","summary":"Biocytogen-B (02315) saw its shares rise more than 7% during the trading session. At the time of writing, the stock was up 5.9%, trading at HK$57.45, with a turnover of HK$33.73 million. The company...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","02315","VXUS","BK4585","BK0216","688796","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121911076","title":"Dual Boost from Policy and R&D! Huabao Fund's Hong Kong Stock Connect Innovative Drug ETF (520880) Rises Over 1%, Led by Biocytogen-B and PegBio Co-B","url":"https://stock-news.laohu8.com/highlight/detail?id=1121911076","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121911076?lang=en_us&edition=fundamental","pubTime":"2026-03-12 10:11","pubTimestamp":1773281490,"startTime":"0","endTime":"0","summary":"On the morning of March 12, the Hong Kong Stock Connect Innovative Drug ETF (520880) showed steady performance during the trading session, with its on-market price currently up 1.23%. The fund's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","BK0216","399441","BK4588","XBI","02315","BK1161","BK4581","688796","BK4585","161726","520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123239224","title":"BIOCYTOGEN-B Shares Surge Over 8% on Strong 2025 Profit Guidance and Accelerated Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=1123239224","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123239224?lang=en_us&edition=fundamental","pubTime":"2026-03-06 10:32","pubTimestamp":1772764348,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) rose more than 8%, with the stock up 8.15% to HK$48.86 at the time of writing. The trading volume was HK$19.20 million. The increase follows the company's release of its 2025...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","02315","BK4588","VT","BK4585","BK1161","VXUS","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152795465","title":"Biocytogen (02315) Reports Unchanged Share Capital in February 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1152795465","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152795465?lang=en_us&edition=fundamental","pubTime":"2026-03-03 16:42","pubTimestamp":1772527333,"startTime":"0","endTime":"0","summary":"Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (stock code: 02315) maintained 110.78 million H shares as of 28 February 2026, with no increase or decrease compared to the previous month. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166481640","title":"BIOCYTOGEN-B Shares Extend Gains with Over 5% Rise Following Strong Preliminary 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1166481640","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166481640?lang=en_us&edition=fundamental","pubTime":"2026-02-27 09:57","pubTimestamp":1772157446,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) rose more than 5% again. At the time of writing, the stock was up 5.09% to HK$55.75, with a turnover of HK$6.6351 million. On February 26, BIOCYTOGEN-B released its preliminary...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","BK4588","VXUS","VT","02315","BK1161","688796","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bbctg.com.cn","stockEarnings":[{"period":"1week","weight":-0.1024},{"period":"1month","weight":0.0507},{"period":"3month","weight":0.333},{"period":"6month","weight":1.4569},{"period":"1year","weight":3.6417},{"period":"ytd","weight":0.6147}],"compareEarnings":[{"period":"1week","weight":0.0217},{"period":"1month","weight":0.0077},{"period":"3month","weight":-0.0442},{"period":"6month","weight":-0.0096},{"period":"1year","weight":0.2269},{"period":"ytd","weight":0.0012}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Biocytogen Pharmaceuticals (Beijing) Co Ltd is a China-based company primarily engaged in the provision of innovative animal models and pre-clinical pharmaceutical research and development services based on its independently developed gene-editing technology. The Company utilizes its self-developed RenMice fully human antibody and T-cell receptor (TCR) mouse platform for large-scale drug discovery and development targeting potential drug targets in the human body. The Company’s main businesses include the sale of innovative animal models, pre-clinical pharmacology and efficacy evaluation services, and antibody development. The Company is also engaged in the provision of gene-editing services. The Company operates its businesses in the domestic market and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.018702},{"month":2,"riseRate":0.75,"avgChangeRate":0.087225},{"month":3,"riseRate":0.5,"avgChangeRate":0.15364},{"month":4,"riseRate":0.5,"avgChangeRate":-0.042487},{"month":5,"riseRate":0.666667,"avgChangeRate":0.14952},{"month":6,"riseRate":0.333333,"avgChangeRate":0.011218},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.033427},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.055975},{"month":9,"riseRate":0.666667,"avgChangeRate":0.092895},{"month":10,"riseRate":0.25,"avgChangeRate":-0.096483},{"month":11,"riseRate":0.5,"avgChangeRate":0.009059},{"month":12,"riseRate":0.5,"avgChangeRate":0.137663}],"exchange":"SEHK","name":"BIOCYTOGEN-B","nameEN":"BIOCYTOGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BIOCYTOGEN-B(02315),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BIOCYTOGEN-B(02315) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BIOCYTOGEN-B,02315,BIOCYTOGEN-B股票,BIOCYTOGEN-B股票老虎,BIOCYTOGEN-B股票老虎国际,BIOCYTOGEN-B行情,BIOCYTOGEN-B股票行情,BIOCYTOGEN-B股价,BIOCYTOGEN-B股市,BIOCYTOGEN-B股票价格,BIOCYTOGEN-B股票交易,BIOCYTOGEN-B股票购买,BIOCYTOGEN-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BIOCYTOGEN-B(02315),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BIOCYTOGEN-B(02315) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}